Safety and Clinical Activity of Multiple Doses of Barzolvolimab, an anti-KIT Antibody, in Patients with Chronic Spontaneous Urticaria

被引:0
|
作者
Maurer, Marcus [1 ]
Metz, Martin [1 ]
Anderson, John [2 ,3 ]
Talreja, Neetu [4 ]
Windom, Hugh [5 ,6 ]
Alvarado, Diego [7 ]
Crowley, Elizabeth [7 ]
Young, Diane [7 ]
Merchant, Kunal [7 ]
Paradise, Elsa [7 ]
Heath-Chiozzi, Margo [7 ]
Bernstein, Jonathan [8 ,9 ]
机构
[1] Charite Univ Med Berlin, Berlin, Germany
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] AlIerVie Hlth, Birmingham, AL USA
[4] Allergy Grp & Treasure Valley Med Res, Boise, ID USA
[5] Univ S Florida, Sarasota, FL USA
[6] Windom Allergy Asthma Sinus, Sarasota, FL USA
[7] Celldex Therapeut, Hampton, NJ USA
[8] Univ Cincinnati, Cincinnati, OH USA
[9] Bernstein Allergy Grp Clin Res Ctr, Cincinnati, OH USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
410
引用
收藏
页码:AB133 / AB133
页数:1
相关论文
共 50 条
  • [1] Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
    Terhorst-Molawi, Dorothea
    Hawro, Tomasz
    Grekowitz, Eva
    Kiefer, Lea
    Merchant, Kunal
    Alvarado, Diego
    Thomas, Lawrence J.
    Hawthorne, Thomas
    Crowley, Elizabeth
    Heath-Chiozzi, Margo
    Metz, Martin
    Maurer, Marcus
    ALLERGY, 2023, 78 (05) : 1269 - 1279
  • [3] Barzolvolimab demonstrates clinical activity in a multiple ascending dose trial in chronic spontaneous urticaria
    Maurer, M.
    Metz, M.
    Anderson, J.
    Talreja, N.
    Windom, H.
    Alvarado, D.
    Crowley, E.
    Young, D.
    Merchant, K.
    Hawthorne, T.
    Paradise, E.
    Heath-Chiozzi, M.
    Bernstein, J.
    ALLERGY, 2023, 78 : 220 - 221
  • [4] Depletion of mast cells with barzolvolimab, an anti-KIT antibody, does not affect mast cell progenitor numbers or function
    Monino-Romero, S.
    Mahnke, N. A.
    Gutsche, A.
    Terhorst-Molawi, D.
    Grekowitz, E. M.
    Kiefer, L. A.
    Alvarado, D.
    Metz, M.
    Siebenhaar, F.
    Scheffel, J.
    Maurer, M.
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (03)
  • [5] Barzolvolimab Improves Urticaria Control and Quality of Life in Patients with Chronic Spontaneous Urticaria: 52-Week Data
    Maurer, Marcus
    Metz, Martin
    Kobielusz-Gembala, Iwona
    Mitha, Essack
    Leflein, Jeffrey
    Gotua, Maia
    Fuentes-Duculan, Judilyn
    Paradise, Elsa
    Ma, Rick
    Green-berg, Steven
    Young, Diane
    Bernstein, Jonathan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) : AB431 - AB431
  • [6] The Anti-KIT Antibody, CDX-0159, Reduces Mast Cell Numbers and Circulating Tryptase and Improves Disease Control in Patients with Chronic Inducible Urticaria (Cindu)
    Terhorst-Molawi, Dorothea
    Hawro, Tomasz
    Grekowitz, Eva
    Kiefer, Lea
    Metz, Martin
    Alvarado, Diego
    Hawthorne, Thomas
    Merchant, Kunal
    Crew, Linda
    Crowley, Elizabeth
    Heath-Chiozzi, Margo
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB178 - AB178
  • [7] Safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria
    Maurer, M.
    Rosen, K.
    Hsieh, H.
    Blogg, M.
    Georgiou, P.
    Braeutigam, M.
    Saini, S.
    ALLERGY, 2012, 67 : 497 - 498
  • [8] Safety of omalizumab in elderly patients with chronic spontaneous urticaria
    Narvaez Fernandez, E. J.
    Mir Ihara, P. K.
    Caballero Molina, T.
    Dominguez-Ortega, J.
    Cabanas Moreno, R.
    Entrala Bueso, A.
    ALLERGY, 2021, 76 : 234 - 234
  • [9] CLINICAL ACTIVITY OF AK002, AN ANTI-SIGLEC-8 ANTIBODY, IN MULTIPLE FORMS OF UNCONTROLLED CHRONIC URTICARIA
    Altrichter, S.
    Staubach, P.
    Pasha, M.
    Rasmussen, H.
    Singh, B.
    Chang, A.
    Kamboj, A.
    Bernstein, J.
    Siebenhaar, F.
    Maurer, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S27 - S28
  • [10] Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria
    Skander, D.
    Allenova, A.
    Maurer, M.
    Kolkhir, P.
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 53 (02) : 91 - 93